Astria Therapeutics
ATXS
ATXS
105 hedge funds and large institutions have $310M invested in Astria Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 115 → 105 (-10)
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
Holders
105
Holding in Top 10
1
Calls
$35K
Puts
–
Top Buyers
| 1 | +$8.9M | |
| 2 | +$7.16M | |
| 3 | +$4.09M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.14M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$1.83M |
Top Sellers
| 1 | -$27.3M | |
| 2 | -$2.85M | |
| 3 | -$2.56M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.44M |
